HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,360.00
-125.00 (-1.93%)
At close: Apr 23, 2026

HLB bioStep Revenue

In the year 2025, HLB bioStep had annual revenue of 74.05B KRW with 27.30% growth. HLB bioStep had revenue of 18.73B in the quarter ending December 31, 2025, with 16.01% growth.

Revenue
74.05B
Revenue Growth
+27.30%
P/S Ratio
1.45
Revenue / Employee
503.74M
Employees
147
Market Cap
107.65B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202574.05B15.88B27.30%
Dec 31, 202458.17B5.35B10.14%
Dec 31, 202352.81B-33.46B-38.79%
Dec 31, 202286.28B21.87B33.96%
Dec 31, 202164.40B5.88B10.05%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DreamCIS 66.63B
P&K Skin Research Center 22.78B
WOOJUNG BIO 37.59B
C&R Research 64.98B
DT&CRO CO. 47.75B
SLS BIO 3.98B
BioInfra 23.15B
Penetrium Bioscience 9.74B
Revenue Rankings